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Protein secretion in Escherichia coli is mediated by
translocase, a multi-subunit membrane protein complex
with SecA as ATP-driven motor protein and the SecYEG
complex as translocation pore. A fluorescent assay was
developed to facilitate kinetic studies of protein trans-
location. Single cysteine mutants of proOmpA were site-
specific labeled with fluorescent dyes, and the SecA and
ATP-dependent translocation into inner membrane ves-
icles and SecYEG proteoliposomes was monitored by
means of protease accessibility and in gel fluorescent
imaging. The translocation of fluorescently labeled
proOmpA was largely independent on the position and
the size of the fluorescent label (up to a size of 13–16 Å).
A fluorophore at the 4 position blocked translocation,
but inhibition was completely relieved in the PrlA4 mu-
tant. The kinetics of translocation of the fluorescently
labeled proOmpA could be directly monitored by means
of fluorescence quenching. Inner membrane vesicles
containing wild-type SecYEG were found to translocate
proOmpA with a turnover of 4.5 molecules proOmpA/
SecYEG complex/min and an apparent Km of 180 nM,
whereas the PrlA4 mutant showed an almost 10-fold in-
crease in turnover rate and a 3-fold increase of the ap-
parent Km for proOmpA translocation.
Translocase is a membrane-bound enzyme complex that me-
diates the translocation across and integration of proteins into
the cytoplasmic membrane of Escherichia coli (for a review see
Ref. 1). Secretory proteins are synthesized in the cytosol as
precursors with an amino-terminal signal sequence targeted to
the membrane and subsequently transported across the mem-
brane in an ATP-dependent manner via a proteinaceous chan-
nel formed by a heterotrimeric membrane protein complex
composed of SecY, SecE, and SecG (2, 3). SecA is a soluble
ATPase that associates with the SecYEG complex (4) where it
serves both as a receptor for precursor proteins (5) and as an
ATP-driven molecular motor (6, 7). Translocation is a stepwise
process that involves cycles of ATP binding and hydrolysis by
SecA and concomitant steps of precursor protein SecA associ-
ation and dissociation. The precursor protein is threaded across
the membrane in steps of 2.5 kDa (7, 8), whereas transloca-
tion can be accelerated by the proton motive force (PMF)1 (7, 9).
During the last decade, the biochemical mechanism of pro-
tein translocation has been studied in great detail. This ad-
vance has been possible attributed to the availability of a
robust in vitro translocation assay. This assay is based on a
method in which radioactively labeled precursor proteins are
added to inner membrane vesicles (IMVs) in the presence of
soluble components (SecA, SecB, and so on) and a suitable
energy source (ATP). Precursor proteins are subsequently
translocated into the lumen of the IMVs whereupon the mem-
branes are treated with externally added proteinase to digest
all nontranslocated substrate, whereas the translocated pro-
tein is inaccessible. The remaining protein is finally analyzed
by SDS-PAGE and autoradiography. Normally, the substrate
proteins are synthesized in a (coupled) transcription/transla-
tion system resulting in radiochemical amounts of protein.
Alternatively, the precursor protein can be isolated from an
overproducing strain, purified, and radiolabeled by means of
iodination. Although the method is reliable, it is time-consum-
ing, discontinuous, and produces radioactive waste. Because of
the use of radiochemical amounts of precursor protein, the
exact substrate concentration is often not known; therefore,
reactions are frequently performed under non-saturating con-
ditions. Especially for quantitative biochemical and kinetic
studies, it is important to obtain exact estimates of initial rates.
In the current era of proteomic studies, there is also an increas-
ing demand for simple and rapid assays that can be automated.
Such systems are in particular useful for high throughput
drug-screening programs.
To overcome the problems associated with the classical pro-
tease accessibility assay, we set out to develop a real-time
fluorescent protein translocation assay. Here, we show that
fluorescently labeled precursor proteins are translocated into
IMVs via an authentic mechanism as validated by a fluorescent
variant of the classical translocation assay. Translocation of
these fluorescent precursor proteins could be directly moni-
tored by means of fluorescence quenching. This allowed a pre-
cise determination of the turnover rate and other kinetic pa-
rameters of protein translocation.
EXPERIMENTAL PROCEDURES
Materials—IMVs with overexpressed or wild-type levels of SecYEG
were derived from E. coli strains KM9 or SF100 transformed with
pET610 (10). SecA (11), His-tagged SecB (12), and SecYEG (3) were
purified as described previously. SecYEG was reconstituted into lipo-
somes of E. coli phospholipids (Avanti polar lipids, Alabaster, AL) by
detergent dilution (3). Maleimide derivatives of fluorescein, Texas Red,
Oregon Green, and Alexa Fluor 633 were from Molecular Probes (Eu-
gene, OR).
Strains and Plasmids—A plasmid encoding proOmpA
(C302S,proOmpA-Cys-290) (pET502) was constructed from pET147 (8)
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by site-directed mutagenesis. Cysteine-less proOmpA-(C290S,C302S)
(pET2345) was constructed with the QuikChange site-directed mu-
tagenesis kit (Stratagene, La Jolla, CA) and used to introduce single
cysteines at positions 4 and 33 of the mature OmpA, yield-
ing pET2346 (D4C,proOmpA-Cys-4) and pET2348 (N33C,proOmpA-
Cys-33). pET502 was used as template to construct the double cys-
teine mutant proOmpA (C302S,D291C,proOmpA-Cys-290,Cys-291)
(pET2349).
Purification and Labeling of proOmpA—ProOmpA was purified as
described previously (13). Prior to labeling, the proOmpA (3.5 mg/ml in
8 M urea, 50 mM Tris-HCl, pH 7.0) was reduced with 1 mM tris-(2-
carboxyethyl)phosphine and incubated with 2 mM fluorescent maleim-
ide at room temperature for 30 min. The reaction was quenched by the
addition of 10 mM dithiothreitol, and the unreacted label was removed
by gel filtration on a P6 spin column (Bio-Rad, Hercules, CA). The
protein was collected by trichloroacetic acid precipitation and resus-
pended in 8 M urea, 50 mM Tris-HCl, pH 7.0. The labeling efficiency was
determined spectroscopically. With Texas Red, double labeling of
proOmpA (C302S,D291C) could be validated by a slower migration on
SDS-PAGE of the double-labeled protein relative to the unlabeled or
single labeled protein.
In Vitro Translocation and Fluorescent Imaging—Translocation of
fluorescently labeled proOmpA into SecYEG proteoliposomes or inner
membrane vesicles was assayed by the accessibility to added proteinase
K (14). Reactions (final volume 50 l) were performed in translocation
buffer (50 mM Hepes-KOH, pH 7.5, 30 mM KCl, 0.5 mg/ml bovine serum
albumin, 10 mM dithiothreitol, 2 mM Mg(OAc)2 with 10 mM phospho-
creatine, 50 g/ml creatine kinase, 20 g/ml SecA, 32 g/ml SecB, 5
g/ml proOmpA) started by the addition of 2 mM ATP, incubated for
various time intervals at 37 °C, and stopped by chilling on ice. Trans-
location reactions were analyzed by proteinase K treatment (8) and
SDS-PAGE and directly visualized in gel with a Roche Lumi-Imager F1
(Roche Molecular Biochemicals). Exposure was for 500 ms up to 1 s. For
the imaging of fluorescein and Oregon Green, Texas Red, and Alexa
Fluor 633, high pass filters were used with a cutoff at 520, 600, and 645
nm, respectively.
Direct Fluorescent Monitoring of in Vitro Protein Translocation—
Translocation of OG-labeled proOmpA was assayed directly using an
Aminco Bowman Series 2 spectrometer (SLM Instruments). Excitation
and emission were set to 491 and 515 nm, respectively, with slit-widths
of 4 nm. Translocation reaction mixtures in a thermostated microcu-
vette with a volume of 150 l were preincubated for 3 min at 37 °C and
started by the addition of 2 mM ATP.
Other Techniques—Protein concentrations were determined using
the Bio-Rad DC protein assay with bovine serum albumin as a stand-
ard. The SecA ATPase activity was assayed as described previously
(14). Western blots were developed with a monoclonal antibody against
proOmpA (3). Scatchard analysis of the binding of SecA to IMVs was
done essentially as described previously (5). The size of various fluores-
cent dyes was estimated after modeling of the chemicals using the
HyperChem package (Hypercube Inc., Gainesville, FL) on a Silicon
Graphics workstation.
RESULTS
Translocation of Fluorescently labeled proOmpA into IMVs—
Wild-type proOmpA contains two cysteine residues at positions
290 and 302. To obtain a uniform fluorescently labeled
proOmpA protein, a single cysteine mutant of proOmpA was
created by replacing the cysteine at position 302 by a serine
(proOmpA-Cys-290). In addition, cysteine at position 290 was
replaced by a serine to obtain a cysteine-less proOmpA that
was used to control the degree of nonspecific labeling. Under
reducing conditions, Cys-less proOmpA and proOmpA-Cys-290
were translocated with an efficiency equal to wild-type
proOmpA as assayed by immunoblotting (data not shown).
With both mutant proOmpA proteins, the proOmpA-stimu-
lated SecA translocation ATPase activity was indistinguish-
able from the wild type (data not shown). Subsequently, the
cysteine mutants were labeled with a maleimide derivative of
the fluorescent probe OG. Spectroscopic analysis showed that
proOmpA-Cys-290 could be labeled with an efficiency of 70%
under conditions that there was only minor labeling of Cys-less
proOmpA (Fig. 1A). This residual background level is probably
because of the presence of some endogenous proOmpA that
co-purifies with the overproduced Cys-less mutant. OG-labeled
proOmpA-Cys-290 was used next in a translocation reaction
with proteoliposomes containing purified SecYEG. Transloca-
tion was assayed by means of the protease protection assay,
and protease-protected fragments were visualized by direct
fluorescent imaging of the SDS-PAGE gel. The presence of
protease-protected full-length fluorescent proOmpA was de-
pendent on SecA, ATP (Fig. 1B), and the SecYEG complex (data
not shown). Similar results were obtained with IMVs bearing
wild-type or overexpression levels of SecYEG (Fig. 1B). In
IMVs, a major fraction of the fluorescent proOmpA was pro-
cessed by leader peptidase, yielding fluorescent mature OmpA
(Fig. 1B). Taken together, these data demonstrate that OG-
labeled proOmpA is translocated in an authentic Sec-depend-
ent manner.
Translocation of Fluorescent proOmpA Is Not Impaired by
the Size of the Dye—The size of OG (10–13 Å) could possibly
influence the kinetics of translocation. Therefore, the translo-
cation kinetics of the fluorescent proOmpA was compared with
the unlabeled proOmpA-Cys-290 by Western blotting. Both
proteins were translocated into SecA-SecYEG proteoliposomes
with similar kinetics (Fig. 1C), demonstrating that Oregon
Green labeling does not significantly interfere with the trans-
location reaction.
To further examine possible size restrictions by the translo-
cation pore, proOmpA-Cys-290 was labeled with fluorescent
dyes of different sizes and translocation was assayed in time.
Of the maleimide probes used (fluorescein, eosin, Alexa Fluor
488, Alexa Fluor 633, and Texas Red), Texas Red maleimide
was the largest fluorescent molecule with a size of 13–16 Å.
However, Texas Red did not interfere with the kinetics of
proOmpA translocation into SecYEG-proteoliposomes (data not
shown) or SecYEG IMVs (Fig. 1D). Even double labeling of
proOmpA with Texas Red on two consecutive cysteines
(proOmpA-Cys-290,Cys-291) did not impair translocation (data
not shown). These data demonstrate that the translocation
pore is sufficiently wide or flexible to allow the translocation of
proOmpA labeled with bulky fluorescent probes measuring up
to at least 16 Å.
A Fluorophore at the 4 Position of proOmpA Interferes with
Translocation—The fluorescent probe OG was attached to
FIG. 1. Fluorescent labeling and translocation of proOmpA. A,
Oregon Green labeling of Cys-less proOmpA and proOmpA-Cys-290. B,
translocation of OG-labeled proOmpA-Cys-290 into SecYEG proteolipo-
somes and in urea-treated IMVs derived from wild-type and SecYEG-
overproducing cells. Translocation reactions were performed in the
presence or absence of SecA (10 g/ml) and 2 mM ATP, C, translocation
of unlabeled and OG-labeled proOmpA-Cys-290 into SecYEG-proteoli-
posomes detected by Western blotting using an anti-body against
proOmpA. D, translocation of fluorescein, Texas Red, and Alexa Fluor
633-labeled proOmpA-Cys-290 into urea-treated IMVs containing over-
expressed SecYEG. The black and open arrows indicate proOmpA and
OmpA, respectively.
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other unique cysteine positions in proOmpA to determine
whether there are positional restrictions. For this purpose, a
unique cysteine was introduced at the 4 position from the
signal sequence cleavage site (proOmpA-Cys-4) and at position
33 (proOmpA-Cys-33). These positions were chosen to map in
loop regions of the OmpA structure to minimize any interfer-
ence of the labeling in the formation of the -sheet structure
(15). Both cysteine mutants were efficiently translocated into
IMVs (data not shown). However, after labeling with OG (Fig.
2A) or Texas Red, the presence of the fluorophore at position 
4 strongly inhibited proOmpA translocation. On the other
hand, OG did not interfere with translocation when the probe
was bound to a cysteine at position 33 (Fig. 2A) or 66
(proOmpA-S66C).2 Strikingly, when the translocation of OG-
labeled proOmpA-Cys-4 mutant was assayed with IMVs bear-
ing the overexpressed PrlA4 mutant (16), translocation was
restored (Fig. 2). This demonstrates that PrlA4 not only sup-
presses secretion defects caused by a defective or missing sig-
nal sequence but that it also restores the translocation of de-
fective precursor proteins with aberrant structural elements
that are not part of the signal sequence.
Real-time Monitoring of the Translocation of Fluorescently
Labeled proOmpA—To study the kinetics of protein transloca-
tion, a real-time spectroscopic assay was developed. Initially,
the translocation of OG-labeled proOmpA-Cys-290 into IMVs
containing overexpressed SecYEG was assayed in the presence
of a membrane-impermeable quencher. For this purpose, p-
xylene-bis-pyridinium bromide and potassium iodine were
tested, because these compounds had no effect on the efficiency
of protein translocation when used at a concentration of 40 and
60 mM, respectively3 (data not shown). Translocation was ini-
tiated by the addition of ATP, and the fluorescence level was
monitored in time. It was reasoned that if the fluorescence of
OG-labeled proOmpA would be quenched at the outside of the
vesicles, translocation of the proOmpA into the vesicles would
result in an increase in fluorescence. However, after the initi-
ation of translocation, instead of an increase, a progressive
decrease in fluorescence was observed to 15% of its initial
value after 5 min. Identical results were obtained when fluo-
rescein or Texas Red-labeled proOmpA was used (data not
shown). Strikingly, in the absence of added quencher, a similar
decrease in fluorescence was observed (Fig. 3A), suggesting
that this phenomenon is caused by an intrinsic quenching
process. This could either be self-quenching, resulting from the
accumulation of precursor protein in the lumen of the IMVs, or
be attributed to the presence of an intrinsic quencher that is
associated with the IMVs. Therefore, further experiments were
performed in the absence of added quencher. The decrease in
fluorescence was dependent on SecA (data not shown) and
hydrolyzable ATP (Fig. 3C) and was inhibited when a 100-fold
excess of unlabeled proOmpA was added as a competitor (Fig.
3B). In the absence of nucleotide or in the presence of ADP or
the non-hydrolyzable ATP analogue AMP-PNP, the fluores-
cence remained constant (Fig. 3C). The presence of an ATP-
regenerating system, i.e. creatine kinase and creatine phos-
phate, stimulated protein translocation (Fig. 3, A and C) (17).
The addition of ATP to IMVs not only energizes SecA but also
results in the generation of a PMF via the proton-pumping
F0F1-ATPase. The transmembrane pH gradient (pH) compo-
nent of the PMF affects the luminal pH of the IMVs. Because
the quantum yield of some fluorophores is pH-dependent, we
had to ascertain that the observed quenching is not caused by
an acidic pH in the lumen of the IMVs. Therefore, the translo-
cation was assayed in the absence and presence of the iono-
phore nigericin (1.5 M) to dissipate the pH. With OG-labeled
proOmpA, nigericin had no effect on the fluorescent signal.
However, when fluorescein was used, the addition of nigericin
resulted in a marked increase in fluorescence (data not shown).
Nigericin had no effect on the decrease in fluorescence with
fluorescein-labeled proOmpA when SecYEG overexpression
IMVs were used derived from an unc strain NN100 (18) or
when urea-treated IMVs were used that are unable to generate
a pH by ATP hydrolysis. Therefore, with fluorescein, quench-
ing is partially caused by a pH-dependent change in fluores-
cence quantum yield. This implies that the fluorescent
proOmpA derivatives are indeed translocated into the lumen of
the IMVs.
To examine whether the decrease in fluorescence was di-
rectly correlated to the amount of translocated proOmpA, sam-
ples were drawn from the fluorescence cuvette at different time
points and further analyzed in a protease protection assay and
in gel fluorescent imaging. The kinetics of the fluorescence
decrease was paralleled by an increase in the amount of pro-
tease-protected proOmpA (Fig. 3D) showing that within this
range a linear relation exists between the quenching of the
fluorescent signal and the amount of translocated proOmpA.
Similar results were obtained when instead of IMVs SecYEG
proteoliposomes were used (data not shown). These data dem-
onstrate that the fluorescent on-line assay can be used for a
direct kinetic analysis.
Kinetics of proOmpA Translocation—To measure true kinet-
ics of protein translocation, it is important that a saturating
concentration of precursor protein is used and that initial rates
conditions are assessed. Both requirements can be met by the
real-time fluorescent assay; therefore, we set out to determine
the turnover number of the translocase in vitro. The number of
translocation sites was determined by Scatchard analysis of
the binding of SecA to SecYEG IMVs. For further calculations,
it was assumed that a single SecA dimer binds to one translo-
cation site (formed by a SecYEG oligomer). For the IMVs bear-
ing overexpressed SecYEG or PrlA4, the number of SecA bind-
ing sites was estimated to be 80 and 35 pmol/mg IMVs,
respectively. The rate of proOmpA translocation was deter-
mined over a wide range of proOmpA concentrations (0–0.9
M) at a fixed IMV concentration and saturating concentra-
tions of the other Sec components (Fig. 4B). With IMVs bearing
the overexpressed SecYEG complex, the turnover appeared
4.5 molecules of proOmpA/translocation site/min with an ap-
parent Km for proOmpA of 180 nM. A marked increase in
turnover was observed with the PrlA4 mutant yielding a value
of 40 molecules of proOmpA/translocation site/min and an ap-
parent Km for proOmpA of 420 nM. Remarkably, with PrlA4
IMVs, also a higher level of fluorescence quenching was ob-
tained as compared with the wild-type SecYEG complex (Fig.
4A). This finding suggests that the PrlA4 mutant is capable of
translocating a larger fraction of the added proOmpA possibly
2 N. Nouwen, unpublished results.
3 P. Natale, unpublished results.
FIG. 2. Translocation of Oregon Green-labeled proOmpA sin-
gle Cys mutants into IMVs derived from cells overexpressing
the SecYEG and PrlA4 complex. The black and open arrows indicate
proOmpA and OmpA, respectively. Membranes were treated with urea
to inactivate the endogenous SecA.
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including some proOmpA that is translocation-incompetent
with the wild-type SecYEG complex. Taken together, these
data demonstrate that the PrlA4 mutation enhances the turn-
over of the functional translocase.
Protein translocation is stimulated by the PMF. To study the
effect of the PMF on the translocation rate, assays were per-
formed in the absence and presence of the ionophores nigericin
and valinomycin (both at 1.5 M). Under these conditions, a
complete loss of the PMF is obtained as confirmed by fluores-
cent pH measurements using the dye 9-amino-6-chloro-2-me-
thoxyacridine (data not shown). Dissipation of the PMF in
SecYEG overexpression IMVs resulted in a3-fold reduction of
the turnover rate to 1.2 molecules of proOmpA/translocation
site/min with no significant change in apparent Km for
proOmpA (Table I). Translocation in the PrlA4 mutant has
been shown to occur largely independent of the PMF (19).
Consistently, the turnover of PrlA4 IMVs was hardly affected
by the dissipation of the PMF, yielding a value of 35 molecules
of proOmpA/translocation site/min and an apparent Km for
proOmpA of 500 nM (Fig. 4B and Table I).
With wild-type SecYEG overexpression IMVs, the apparent
Km values for SecA and ATP were determined for the translo-
cation of OG-labeled proOmpA (Fig. 4, C and D). IMVs were
treated with urea to inactivate SecA and other ATPases. Urea
treatment results in a reduction of the turnover of the trans-
locase from 4.5 to 0.5 proOmpA/translocation site/min, which is
only partially caused by the loss of a PMF. The kinetic analysis
revealed that for proOmpA translocation, the apparent Km
values for SecA and ATP are 50 nM and 45 M, respectively
(Table I).
DISCUSSION
The availability of an efficient in vitro protein translocation
system has resulted in major advances in our understanding of
bacterial protein secretion. Essentially, this reaction monitors
the movement of a translocation-competent precursor protein
into the lumen of the isolated inner membrane vesicles or
proteoliposomes by their protection against treatment with an
externally added protease. Protease-protected polypeptide
fragments are visualized by Western blotting or autoradiogra-
phy and, if necessary, quantified by densitometry. This method
allows the detection of fully translocated precursor proteins,
processed forms, and even of translocation intermediates of
which only the translocated amino-terminal fragments become
protected against protease treatment. Because the protease
accessibility method is discontinuous, i.e. time points are taken
at various intervals, kinetic studies are rather complex. In
addition, the visualization is time-consuming (hours to days)
and difficult to implement in high throughput drug-screening
protocols or other robotics-driven technologies. Here, we show
that when a fluorescently labeled proOmpA is used as sub-
strate, protein translocation can be detected more rapidly and
even followed in real time. Instead of radiolabeled fragments,
the polypeptide bands can be readily detected by in gel fluores-
cence imaging with a sensitivity that is at least similar to that
with radioactivity but requires only a fraction of the time
(within a few min). Similar results have been obtained with the
fluorescently labeled maltose-binding protein.2 Therefore, the
method appears generally applicable for studies on posttrans-
lational translocation.
By direct spectroscopic monitoring, the translocation of Or-
FIG. 3. Real-time monitoring of
proOmpA translocation. A, OG-labeled
proOmpA (4 g/ml) was preincubated for
3 min at 37 °C in the presence of SecA,
his-SecB, and IMVs containing overex-
pressed SecYEG. Translocation was
started by the addition of ATP (2 mM)
(black line) or translocation buffer (gray
line). The initial drop in the fluorescence
is because of dilution of the sample after
the addition of ATP (indicated by open
arrow). No corrections were applied. B,
translocation of OG-labeled proOmpA (2
g/ml) into IMVs in the presence (gray) or
absence (black) of a 100-fold excess of un-
labeled proOmpA. Translocation was
started by the addition of 2 mM ATP (in-
dicated by open arrow). C, translocation of
proOmpA in the presence of ADP, AMP-
PNP, ATP, and ATP with an ATP-regen-
erating system (ATPE-mix) or in the ab-
sence of nucleotides. D, direct comparison
of the translocation of proOmpA-Cys-
290-OG as measured spectroscopically
and by protease protection assay using
immunoblotting for detection. Protease-
protected proOmpA was quantified with
OptiQuant 3.00 software (Packard In-
strument Co.). The values are an average
of three independent experiments.
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egon Green-labeled proOmpA into the IMVs could also be fol-
lowed in real time. This probe is rather insensitive to pH and
ionic composition of the buffer solution. Conditions that specify
an authentic SecA and ATP-dependent reaction yield a time-
dependent decrease in the fluorescence, which corresponds to
the translocation of the fluorescent precursor into the lumen of
the vesicles. A similar phenomenon is observed when proOmpA
is labeled with fluorescein or Texas Red. The observed quench-
ing is 1) dependent on the presence of SecYEG, SecA, and
hydrolyzable ATP; 2) competitively inhibited by an excess un-
labeled proOmpA; and 3) the kinetics of the fluorescence de-
crease correspond to the kinetics of protein translocation as
assayed by the classical protease-protection method. In the
case of fluorescein-labeled proOmpA-(Cys-290), the fluores-
cence signal appeared dependent on the pH. This effect, how-
ever, is caused by the acidic luminal pH that reduced the
fluorescence quantum yield of translocated labeled precursor
protein. Interestingly, this implies that the carboxyl-terminal
region of the protein must have crossed the membrane. There-
fore, we conclude that the decrease in fluorescence represents
an authentic translocation reaction.
The exact mechanism of quenching of the fluorescence of the
FIG. 4. Kinetic analysis of proOmpA translocation. A, translocation of OG-labeled proOmpA into IMVs containing overexpressed wild-type
SecYEG (solid) or PrlA4 (dashed). B, initial rate of proOmpA in SecYEG (black) or PrlA4 (white) overexpression IMVs in the presence (E) or absence
(‚) of a PMF as a function of the proOmpA concentration. Translocation rates were measured at 0–0.9 M proOmpA-Cys-290-OG, 0.25–1 M SecB,
0.1 M SecA, 2 mM ATP, and 0.1 mg/ml IMVs. C, initial rate of proOmpA translocation in SecYEG IMVs as a function of the SecA concentration.
Rates were measured with 0.2 M proOmpA-Cys-290-OG, 0.5 M SecB, 2 mM ATP, and 50 g/ml urea-treated SecYEG IMVs. D, initial rate of
proOmpA translocation into SecYEG IMVs as a function of the ATP concentrations. Rates were determined with 0.1 M proOmpA-Cys-290-OG,
0.25 M SecB, 0.1 M SecA, and 50 g/ml urea-treated SecYEG IMVs.
TABLE I
Kinetics parameters of protein translocation
Parameters were determined under the conditions described in Fig. 4. Values determined in the presence of the ionophores nigericin/valinomycin
are given within brackets.
proOmpA SecA ATP
Turnovera Apparent Km Apparent Km Apparent Km
proOmpA/site/min nM nM M
SecYEG 4.5 (1.2) 180 (280) 50 45
PrlA4 40 (35) 420 (500)
a Assuming a SecA dimer per translocation site.
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precursor protein during translocation is unclear. The concen-
trative effect of the translocation reaction that accumulates the
precursor protein into a small vesicle lumen could result in
self-quenching. However, preliminary rapid mixing experi-
ments suggest that the quenching is observed directly (within
the first few seconds) after the onset of translocation, even in
the case that the fluorophore is conjugated with a cysteine
(Cys-290) in the COOH terminus. Alternatively, the phenome-
non may be caused by the presence of intrinsic quenchers in the
membrane, although it should be emphasized that the same
reaction was observed with SecYEG proteoliposomes formed
from isolated E. coli phospholipids. Another possibility is that
the environment of the fluorescent probe changes when it is
translocated, for instance, as a result of folding at the trans-
side of the membrane after the release from the translocation
pore. Because the fluorescence quenching is linearly related to
the amount of proOmpA molecules translocated, the assay is
quantitative and can be used to determine the kinetic param-
eters for the translocation. The turnover number for the wild-
type SecYEG complex is 4.5 molecules of proOmpA translo-
cated/site/min, assuming that a translocation site corresponds
to a high affinity binding site for the SecA dimer. The apparent
Km for proOmpA was 180 nM. The turnover number was re-
duced 3-fold upon the dissipation of the PMF (19), without
significant change in the apparent Km value. Strikingly, the
PrlA4 mutant was found to be almost 10-fold more active as the
wild type when saturated with proOmpA, whereas the appar-
ent Km for proOmpA was increased to 420 nM. The kinetic
studies confirm that translocation by the PrlA4 mutant is
barely affected by the dissipation of the PMF (19) and further
demonstrate that the PrlA4 mutant is a highly active translo-
case. Further kinetic studies on proOmpA translocation
showed that the apparent Km for SecA is 50 nM, which is
3-fold higher as the Kd value reported for the binding of SecA
to the SecYEG complex (13 nM) (20). The apparent Km values
for proOmpA is in the same range as reported for a chimeric
protein containing the signal sequence of E. coli alkaline phos-
phatase and the mature portion of staphylococcal nuclease
(570 150 nM) as assessed by the precursor protein-stimulated
translocation ATPase activity of SecA (21).
The SecYEG complex forms a protein conducting channel
across the membrane, but the exact size of the pore is not
known. Various structural studies have shed some light on the
possible size limits of the pore. Negative stain electron micros-
copy and mass measurements with the scanning transmission
electron microscope suggest that the SecYEG complex tet-
ramerizes under translocation conditions to form a large ring-
like structure with a central 4–5-nm wide stain-filled pit (3). In
a recent blue native gel study, trapped precursor proteins were
found to associate with a SecYEG dimer (22). Cryoelectronmi-
croscopy and three-dimensional reconstruction of layered two-
dimensional crystals of the dimeric SecYEG complex indicate
that this structure lacks a central opening (23). Therefore, the
SecYEG dimer structure either represents a closed state of the
translocase or a building block for the assembly of a tetrameric
pore-like structure. The ribosome-attached Sec61p complex
also forms a ringlike structure with a central opening of2 nm
(24). It has been suggested that these rings accommodate a
trimer of the Sec61p complex. Studies on the accessibility of a
fluorescent probe that is attached to translocating polypeptide
chains to quencher of various sizes (25) suggest that the chan-
nel is large, possibly 4–6 nm under translocation conditions.
The pore of the active E. coli translocase may also be signifi-
cantly larger than required for the translocation of an unfolded
polypeptide chain. Although large folded proteins such as bo-
vine pancreas trypsin inhibitor and dihydrofolate reductase
block translocation (7, 26), a disulfide-bridged polypeptide loop
up to 18 amino acid residues in proOmpA can still be trans-
ported across the membrane provided that a PMF is present
(27). Our studies with fluorescently labeled proOmpA indicate
that a bulky fluorescent dye such as Texas Red (size of 13–16 Å)
is readily translocated. Even proOmpA labeled with Texas Red
at two consecutive cysteines was tolerated, suggesting that the
translocation pore must have a sufficiently wide flexible struc-
ture to allow a large variety of chemical groups, even in the
absence of a proton motive force.
The kinetic data demonstrate that translocation is a rapid
event. With the wild-type SecYEG complex, the turnover per
SecA dimer is close to one precursor protein every 10 s. A single
E. coli cell consists of 2,350,000 proteins of which 33% is
located in the inner membrane, periplasm, or outer membrane
(28). In a cell that doubles every 40 min, approximately 20,000
proteins need to be transported across or inserted into the
membrane/min (29). Assuming that50% of these proteins are
indeed translocated (or membrane-inserted) via the SecYEG
complex, the experimentally determined turnover number of
4.5 would require 2,000 translocation sites. The number of
SecY molecules in a cell has been only been estimated at 500
(30), whereas the number of active translocation pores is pre-
sumably less as single pore consists of multiple SecYEG com-
plexes. This would mean that the in vitro estimated turnover is
insufficient to explain in vivo translocation. However, this
value is certainly an underestimate. For instance, intact me-
tabolizing cells maintain a much higher PMF (up to 200 mV)
as compared with IMVs with ATP as energy source (approxi-
mately 80 mV), whereas other stimulatory factors such as
SecDFyajC complex may further add to the activity. Moreover,
the in vitro reaction is known to be uncoupled (9, 31) with
unproductive translocation initiation events (32).
In conclusion, the use of fluorescently labeled precursor pro-
teins allowed for the first time the real-time monitoring of
protein translocation and a direct assessment of kinetic data.
This novel method is generally applicable to other protein
translocation system and provides new avenues to study pro-
tein translocation including single molecule spectroscopy and a
high throughput automation of the translocation reaction.
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